The majority of keratinocytes incorporate intradermally injected plasmid DNA regardless of size but only a small proportion of cells can express the gene product.

The expression of intradermally injected DNA by keratinocytes is found mainly in the upper and middle layers of the epidermis. To investigate the mechanism of this selective expression, we observed the sequential changes in the distribution of interleukin-6-expressing keratinocytes after the introduction of the interleukin-6 gene. Transgene expression first occurred in basal keratinocytes and subsequently expanded to all epidermal layers and then remained in the upper layers. Semiquantitative analysis indicated that keratinocytes in the lower layers incorporated and lost DNA earlier than those in the upper layers. In order to examine the effect of the DNA size on the transgene expression, we constructed a plasmid containing a full-length 9 kb cDNA of type VII collagen and introduced it into keratinocytes. The expression pattern of type VII collagen in the epidermis was the same as those for smaller genes. This suggests that plasmid size has little or no effect on the expression pattern of the transfected gene. To trace the introduced plasmid, we intradermally injected a green fluorescence protein expression plasmid coupled with a rhodamine flag. Almost all keratinocytes in the injected areas showed rhodamine fluorescence. Furthermore, some cells also expressed green fluorescence protein. A lack of rhodamine fluorescence in the nucleus suggested an impairment of plasmid DNA transport from the cytoplasm to the nucleus. Collectively, our results show that the majority of keratinocytes take up the intradermally injected DNA regardless of its size, but that the transfer of DNA from the cytoplasm to the nucleus is limiting the transgene expression.

[1]  J. Vogel,et al.  Nonviral skin gene therapy. , 2000, Human gene therapy.

[2]  L. Taichman,et al.  Virus-mediated gene transfer for cutaneous gene therapy. , 2000, Human gene therapy.

[3]  Mei Chen,et al.  Development and Characterization of A Recombinant Truncated Type VII Collagen “Minigene” , 2000, The Journal of Biological Chemistry.

[4]  K. Tamai,et al.  In vivo gene introduction into keratinocytes using jet injection , 1999, Gene Therapy.

[5]  Masanori Sato,et al.  In vivo introduction of the interleukin 6 gene into human keratinocytes: induction of epidermal proliferation by the fully spliced form of interleukin 6, but not by the alternatively spliced form , 1999, Archives of Dermatological Research.

[6]  P. White,et al.  Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice. , 1999, The Journal of investigative dermatology.

[7]  J. Miyazaki,et al.  Promoter/enhancer cassettes for keratinocyte gene therapy. , 1999, The Journal of investigative dermatology.

[8]  K. Tamai,et al.  Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. , 1998, Journal of immunology.

[9]  P. Khavari Gene therapy for genetic skin disease. , 1998, The Journal of investigative dermatology.

[10]  E. Canning,et al.  A triploblast origin for Myxozoa? , 1998, Nature.

[11]  H. Ishida,et al.  Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. , 1998, The Journal of clinical investigation.

[12]  K. Tamai,et al.  In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method. , 1997, The Journal of investigative dermatology.

[13]  U. Hengge,et al.  Expression of naked DNA in human, pig, and mouse skin. , 1996, The Journal of clinical investigation.

[14]  U. Hengge,et al.  Cytokine gene expression in epidermis with biological effects following injection of naked DNA , 1995, Nature Genetics.

[15]  D. Roop,et al.  Epidermis: an attractive target tissue for gene therapy. , 1994, The Journal of investigative dermatology.

[16]  J. Uitto,et al.  Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. , 1994, The Journal of biological chemistry.

[17]  J. Vogel,et al.  Keratinocyte gene therapy. , 1993, Archives of dermatology.

[18]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[19]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[20]  U. Hengge,et al.  Uptake of DNA by Keratinocytes , 2001 .

[21]  K. Tamai,et al.  In vivo gene transfer method in keratinocyte gene therapy: intradermal injection of DNA complexed with high mobility group-1 protein in rats. , 2000, Acta dermato-venereologica.

[22]  O. Zelphati,et al.  Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA. , 1999, Human gene therapy.